- Home
- CTMX vs SNAL Comparison
CTMX vs SNAL Comparison
Compare CTMX & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- SNAL
- Stock Information
- Founded
- CTMX 2008
- SNAL 2000
- Country
- CTMX United States
- SNAL United States
- Employees
- CTMX N/A
- SNAL N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- SNAL Computer Software: Prepackaged Software
- Sector
- CTMX Health Care
- SNAL Technology
- Exchange
- CTMX Nasdaq
- SNAL Nasdaq
- Market Cap
- CTMX 444.3M
- SNAL 50.2M
- IPO Year
- CTMX 2015
- SNAL 2022
- Fundamental
- Price
- CTMX $2.50
- SNAL $1.56
- Analyst Decision
- CTMX Strong Buy
- SNAL
- Analyst Count
- CTMX 2
- SNAL 0
- Target Price
- CTMX $5.00
- SNAL N/A
- AVG Volume (30 Days)
- CTMX 2.6M
- SNAL 86.5K
- Earning Date
- CTMX 08-07-2025
- SNAL 08-12-2025
- Dividend Yield
- CTMX N/A
- SNAL N/A
- EPS Growth
- CTMX 128.27
- SNAL N/A
- EPS
- CTMX 0.49
- SNAL 0.04
- Revenue
- CTMX $147,557,000.00
- SNAL $90,462,190.00
- Revenue This Year
- CTMX N/A
- SNAL $24.50
- Revenue Next Year
- CTMX N/A
- SNAL $20.27
- P/E Ratio
- CTMX $5.15
- SNAL $41.76
- Revenue Growth
- CTMX 23.81
- SNAL 46.95
- 52 Week Low
- CTMX $0.40
- SNAL $0.52
- 52 Week High
- CTMX $3.10
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- CTMX 57.13
- SNAL 64.85
- Support Level
- CTMX $2.15
- SNAL $1.34
- Resistance Level
- CTMX $2.44
- SNAL $1.73
- Average True Range (ATR)
- CTMX 0.22
- SNAL 0.20
- MACD
- CTMX -0.03
- SNAL 0.02
- Stochastic Oscillator
- CTMX 41.67
- SNAL 58.22
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.